Corcept Therapeutics Incorporated (CORT) stock news · P/E 245, rev $761.4M
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
This CORT news page leads with what Corcept Therapeutics Incorporated filed — not a scraped headline mill.
No cached 8-K sentence for CORT yet. We will not pad this page with generic market recap.
Latest reported CORT revenue for 2025-12-31 was $761.4M. Net income was $99.7M. Revenue was up 12.8% from 2024-12-31 to 2025-12-31. CORT currently screens at market cap $7.46B and trailing P/E 244.8.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CORT stock page; for the tape open the quote page.
CORT stock news FAQ
What are CORT's latest revenue and net income?
Latest cached Corcept Therapeutics Incorporated (CORT) revenue for Dec 31, 2025 was $761.4M. Net income was $99.7M. Statements: https://lician.com/financials/cort
How did CORT revenue change from the prior cached period?
Cached Corcept Therapeutics Incorporated (CORT) revenue was up 12.8% from $675.0M (Dec 31, 2024) to $761.4M (Dec 31, 2025). Statements: https://lician.com/financials/cort
What is CORT's P/E ratio?
Corcept Therapeutics Incorporated (CORT) trailing P/E is 244.8 on the latest cached fundamentals snapshot.
What is CORT's market cap?
Corcept Therapeutics Incorporated (CORT) market cap is $7.46B on the latest cached fundamentals snapshot.
What kind of company is CORT?
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Where is CORT stock news listed?
Cached stock news for Corcept Therapeutics Incorporated (CORT) is listed at https://lician.com/news/cort. Filings: https://lician.com/sec/cort
Not investment advice.